Article Detail - JE Part A
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R11 - Effective May 17, 2020
Date Posted: January 29, 2026
This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: May 17, 2020
Summary of Changes:
Revision 9 (R9) incorrectly stated this revision is effective 2/10/2020. The correct effective date of this revision is 5/17/2020.
Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.